Amanote Research
Register
Sign In
Design and Synthesis of Dual Peroxisome Proliferator-Activated Receptors G and D Agonists as Novel Euglycemic Agents With a Reduced Weight Gain Profile
doi 10.1021/jm060617c.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors With Core Hopping Approach
PLoS ONE
Multidisciplinary
Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Drugs and the Peroxisome Proliferator Activated Receptors
Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
PPAR Research
Drug Discovery
Pharmacology
Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus
Therapeutic Advances in Gastroenterology
Gastroenterology
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs
International Journal of Medicinal Chemistry
Biochemistry
Drug Discovery
Molecular Medicine
Peroxisome Proliferator-Activated Receptors (Ppars) in Health and Disease.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Biochemistry
Medicine
Genetics
Molecular Biology
Peroxisome Proliferator-Activated Receptor Gamma Agonists in Renal Disease
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
P633H, a Novel Dual Agonist at Peroxisome Proliferator-Activated Receptors Α and Γ, With Different Anti-Diabetic Effects Indb/Dband KK-Aymice
British Journal of Pharmacology
Pharmacology
